Home › Funds › PORTLAND INVESTMENT COUNSEL INC. › TLX

PORTLAND INVESTMENT COUNSEL INC. position in TLX

TELIX PHARMACEUTICAL LTD · Health Care

PORTLAND INVESTMENT COUNSEL INC. reported holding 266,200 shares of TLX (TELIX PHARMACEUTICAL LTD) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 0.86% of its reported portfolio and ranking #16 among its reported holdings. PORTLAND INVESTMENT COUNSEL INC. has disclosed TLX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)266.20K sh
Reported value held$2.92M
Portfolio Weight0.86%
First reportedQ3 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PORTLAND INVESTMENT COUNSEL INC.'s TLX position evolved

PORTLAND INVESTMENT COUNSEL INC. first disclosed a stake in TLX in Q3 2025 at 128,000 shares (US$1.2M). The position peaked in Q2 2026 at 266,200 shares, worth US$3.1M. Across 5 filings, PORTLAND INVESTMENT COUNSEL INC. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 266,200 shares valued at US$2.9M. Notable position changes include a 108% increase in Q4 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 128.00K $1.22M New
Q4 2025 266.20K $2.06M Add
Q1 2026 266.20K $2.55M Hold
Q2 2026 266.20K $3.07M Hold
Q3 2026 266.20K $2.92M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TLX and 13F data

TLX (TELIX PHARMACEUTICAL LTD) is a Health Care company. 63 other funds we track also report a position in TLX. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TLX

No other tracked fund reports a position in TLX.

All TLX fund holders →

FAQ

How long has PORTLAND INVESTMENT COUNSEL INC. held TLX?

PORTLAND INVESTMENT COUNSEL INC. has disclosed TLX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is PORTLAND INVESTMENT COUNSEL INC.'s current position in TLX?

As of Q3 2026, PORTLAND INVESTMENT COUNSEL INC. holds 266.20K shares of TLX (TELIX PHARMACEUTICAL LTD), valued at $2.92M, representing 0.86% of its reported portfolio and ranking #16.

Has PORTLAND INVESTMENT COUNSEL INC. been buying or selling TLX?

In the latest 13F filing (Q3 2026), PORTLAND INVESTMENT COUNSEL INC. held unchanged its position in TLX. The position peaked in Q2 2026 at 266.20K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.